Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
QuintilesIMS
Accenture
Federal Trade Commission
Fish and Richardson
Farmers Insurance
Johnson and Johnson
Healthtrust

Generated: July 23, 2018

DrugPatentWatch Database Preview

Bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride and what is the scope of bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride freedom to operate?

Bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
is the generic ingredient in two branded drugs marketed by Braintree and Novel Labs Inc, and is included in two NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. One supplier is listed for this compound.
Summary for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride

US Patents and Regulatory Information for bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novel Labs Inc PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL 202217-001 Aug 20, 2014 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Braintree HALFLYTELY bisacodyl; polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL 021551-003 Jul 16, 2010 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Julphar
Mallinckrodt
Medtronic
Chinese Patent Office
Accenture
McKesson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.